To further estimate whether radiosensitization occurs in a majority of HPV-positive HNSCC cells, we tested dual PARP/Wee1 targeting in three additional strains, all of which were also sensitized, two very effectively and UPCI-SCC-90 to less extent (Figure 5C). This evidence concerns the gene PARP1 and head and neck squamous cell carcinoma.